MENU
KYTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Kyverna Therapeutics (KYTX) Earnings Date & Reports

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

A.I. Advisor
published Earnings

KYTX is expected to report earnings to rise 17.54% to -101 cents per share on August 18

Kyverna Therapeutics KYTX Stock Earnings Reports
Q2'25
Est.
$-1.02
Q4'24
Beat
by $0.08
Q3'24
Beat
by $0.04
Q2'24
Beat
by $0.11
The last earnings report on March 27 showed earnings per share of -86 cents, beating the estimate of -94 cents. With 121.19K shares outstanding, the current market capitalization sits at 143.92M.
View a ticker or compare two or three
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. KYTX showed earnings on March 27, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
5980 Horton Street
Phone
+1 510 925-2492
Employees
96
Web
https://www.kyvernatx.com